Effect of neprilysin inhibition on renal function in patients with type Diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
Packer M, Claggett B, Lefkowitz MP, et al.
Lancet Diabetes Endocrinol. Pub. online 13 April 2018